|
|||||
|
|
Codon 72 polymorphism of TP53 gene is a novel prognostic marker for therapy in multiple myeloma |
|
| Authors: | Yutaka Hattori Yurika Ikeda Yuya Suzuki Daiju Ichikawa Maiko Matsushita |
| Affiliation: | Division of Clinical Physiology and Therapeutics, Keio University Faculty of Pharmacy, , Tokyo, Japan |
| Abstract: | |
| Keywords: | multiple myeloma codon 72 polymorphism of TP53 thalidomide prognosis |